- Filed
- Apr 19, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2021 · Apr 16, 2021 | 6.69M sh |
| Cash And Equivalents | Q2 2021 · Feb 28, 2021 | $2.04K |
| Cash And Equivalents | Q2 2021 · Aug 31, 2020 | $2.58K |
| Cash And Equivalents | Q2 2021 · Feb 29, 2020 | $3.5K |
| Cash And Equivalents | Q2 2021 · Aug 31, 2019 | $10.25K |
| Total Liabilities | Q2 2021 · Feb 28, 2021 | $364.22K |
| Total Liabilities | Q2 2021 · Aug 31, 2020 | $247.07K |
| Total Assets | Q2 2021 · Feb 28, 2021 | $21.06K |
| Total Assets | Q2 2021 · Aug 31, 2020 | $2.88K |
| Operating Cash Flow restated | Q2 2021 · Feb 29, 2020 | −$95.31K |
| Sga Expense restated | Q2 2021 · Feb 29, 2020 | $126.61K |
| Sga Expense restated | Q2 2021 · Feb 29, 2020 | $127.99K |
| Net Income restated | Q2 2021 · Feb 29, 2020 | −$119.82K |
| Net Income restated | Q2 2021 · Feb 29, 2020 | −$104.31K |
| Operating Income restated | Q2 2021 · Feb 29, 2020 | −$126.61K |
| Operating Income restated | Q2 2021 · Feb 29, 2020 | −$117.9K |
| Gross Profit | Q2 2021 · Feb 29, 2020 | $10.1K |
| Revenue | Q2 2021 · Feb 29, 2020 | $10.1K |
| Stockholders Equity restated | Q2 2021 · Nov 30, 2019 | $36.42K |
| Stockholders Equity restated | Q2 2021 · Aug 31, 2019 | $20.91K |